Biosample Id,Associated Study,Processing Type,Raw Data File,Raw Data Object Alt Id,Processed Data Directory,mass spec configuration name,lc config name,instrument used,processing institution,instrument analysis start date,instrument analysis end date,execution resource
nmdc:biosamp:12-233,nmdc:sty-11-8fb6t785,MPLEX,/Users/zalm693/development/nmdc_ingest/example_lip_data/raw/raw_data_test1.raw,https://status.my.emsl.pnl.gov/view/1834808,/Users/zalm693/development/nmdc_ingest/example_lip_data/processed/sample1_ms1_processed,"EMSL lipidomics DDA mass spectrometry method, positive",EMSL GC method for polar metabolites,15T FT-ICR MS ,EMSL,01/22/2023,03/04/2024,EMSL-RZR
nmdc:biosamp:12-233,nmdc:sty-11-8fb6t785,MPLEX,/Users/zalm693/development/nmdc_ingest/example_lip_data/raw/raw_data_test2.raw,https://status.my.emsl.pnl.gov/view/1834808,/Users/zalm693/development/nmdc_ingest/example_lip_data/processed/sample1_ms2_processed,"EMSL lipidomics DDA mass spectrometry method, negative",EMSL LC method for non-polar metabolites,12T FT-ICR MS ,EMSL,01/22/2023,03/04/2024,EMSL-RZR
nmdc:biosamp:13-234,nmdc:sty-11-8fb6t785,MPLEX,/Users/zalm693/development/nmdc_ingest/example_lip_data/raw/raw_data_test3.raw,https://status.my.emsl.pnl.gov/view/1554809,/Users/zalm693/development/nmdc_ingest/example_lip_data/processed/sample2_ms1_processed,"EMSL lipidomics DDA mass spectrometry method, positive",EMSL GC method for polar metabolites,VOrbiETD04,EMSL,01/22/2023,03/04/2024,EMSL-RZR
nmdc:biosamp:13-234,nmdc:sty-11-8fb6t785,MPLEX,/Users/zalm693/development/nmdc_ingest/example_lip_data/raw/raw_data_test4.raw,https://status.my.emsl.pnl.gov/view/1554809,/Users/zalm693/development/nmdc_ingest/example_lip_data/processed/sample2_ms2_processed,"EMSL lipidomics DDA mass spectrometry method, negative",EMSL LC method for non-polar metabolites,GC-MS,EMSL,01/22/2023,03/04/2024,EMSL-RZR